Senaste nytt
- DKK 1,3 billion for grand research
- Collaboration brings next generation drugs
- Prenatal testing breakthrough
- Trio goes in for high tech medicines
- Swiss allergy therapy convinces
- Bio-Linux goes global
- SDU professor helps EU
- Medicult acquires embryo scanner
- Danish discovery could help cardiac patients
- Lund honours milieu enthusiast
- Biogaia's advance goes on
- Blood type decide resistance to HIV
- Norwegian describes scrapie gene
- New CEO to Swedish Tillotts Pharma
- Elekta gets ok from China
- Recipharm launches into biologics manufacturing
- New Nordic nutrition collaboration
- Danish biorefinery can save US billions
- New faces in Pronova Biopharma team
- EU grants project on toxicity of nanomaterials
- Acadia drug awarded
- New Nordic biotech company
- Danish focus on bio chemicals
- Danish focus on bio chemicals
- Danish focus on bio chemicals
- Danish focus on bio chemicals
- Danish focus on bio chemicals
- Medtech giant separates
- Bio engineering breakthrough in Denmark
- New influenza vaccine to EU
- Orion cuts 205 jobs
- Cancer cells cheat suicide call
- New nano professor in Denmark
- Control of blood vessels can treat obesity
- Swedish cancer therapy granted
- Mathematician new dean at DTU
- Glucose facilitates the use of indigo
- Pfizer buys Swiss vaccines
- New head of Vinnova
- Sales Representative, Applied Biosystems
- Meda gets access to Asia
- New tools to fight bacteria
- Academy for a new turn at work
- Fat cells' reaction differs with body weight
- Bring talent to those in need
- Ambassador program makes MVA big in Japan
- Martin Bergö: "The Idea is the Thing"
- New management at Øresund
- A platform for dialogue
- New firm based on SLU research
- Time to save for survival
- Grape extract kills cancer cells
Medlemsnytt
- Upcoming ZEISS webinars
- Innovation Rocks webinar recordings now online
- Upgrade for more safety
- Sino Biological and Ainnocence Partnership
- Snabb, energisnål 3-ports magnetventil med utökat flöde
Mest läst
- Besvikelse efter ofullständig studie – Immunovias aktie faller på börsen
- Stockholm missade internationell kongress med tre röster
- Biotechbolag får vite för felaktigt pressmeddelande
- Efterlängtad framgång för Oncopeptides – får grönt ljus i EU
- Innovationshubben i Matfors har haft sin första kund – "Full fart nu"